Mogamulizumab-kpkc Intravenous and Polycitra-LC
Determining the interaction of Mogamulizumab-kpkc Intravenous and Polycitra-LC and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: citric acid / potassium citrate / sodium citrate
Brand name: Cytra-3, Polycitra, Polycitra-LC, Tricitrates, Virtrate-3
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Polyethylene Glycol 3350 NF PEGYLAX
- Mogamulizumab-kpkc Intravenous-Polyethylene Glycol
- Mogamulizumab-kpkc Intravenous-Polyethylene glycol 3350
- Mogamulizumab-kpkc Intravenous-Polyethylene glycol 3350 and electrolytes
- Mogamulizumab-kpkc Intravenous-Polyethylene glycol 3350, electrolytes, and ascorbic acid
- Mogamulizumab-kpkc Intravenous-Polyethylene glycol 3350, sodium and potassium salts
- Polycitra-LC-Molindone
- Polycitra-LC-Mometasone (Oral Inhalation)
- Polycitra-LC-Mometasone and Formoterol
- Polycitra-LC-Mometasone and formoterol Inhalation
- Polycitra-LC-Mometasone Cream
- Polycitra-LC-Mometasone Furoate